Vera Therapeutics, Inc. VERA

Updated: 11 Jun 2026

NASDAQ | Biotech | Immunology and inflammatory disease treatments

No signal published yet

We already track Vera Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Vera Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Immunology and inflammatory disease treatments
We're already tracking Vera Therapeutics, Inc. — here are the latest events we've registered

Recent News

  • On June 2, 2026, Vera Therapeutics announced alignment with the FDA on an earlier analysis plan for its Phase 3 ORIGIN 3 trial, potentially accelerating the path to full approval for atacicept. The FDA has assigned a PDUFA target action date of July 7, 2026, for the drug's potential accelerated approval in treating IgA nephropathy.

What Firelda Watch includes for Vera Therapeutics, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Vera Therapeutics, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Bioarctic
BIOA B
BUY
Swedish Orphan Biovitrum AB (publ)
SOBI
HOLD
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL

Biotech

More companies in this sector

Want to follow Vera Therapeutics, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Vera Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Vera Therapeutics, Inc. VERA
Vera Therapeutics — follow and we'll monitor it
Follow Vera Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.